Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли Peter J Arduini. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что Peter J Arduini сообщил о владениях или сделках со следующими компаниями:
Безопасность | Заголовок | Последние зарегистрированные холдинги |
---|---|---|
US:GEHC / GE HealthCare Technologies Inc. | President and CEO, Director | 167 882 |
US:BMY / Bristol-Myers Squibb Company | Director | 38 266 |
US:GE / General Electric Company | Senior Vice President | 63 044 |
US:IART / Integra LifeSciences Holdings Corporation | President & CEO, Director | 0 |
US:BAX / Baxter International Inc. | Corporate Vice President | 76 800 |
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной Peter J Arduini. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
Инсайдерские покупки IART / Integra LifeSciences Holdings Corporation – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в IART / Integra LifeSciences Holdings Corporation. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
---|---|---|---|---|---|---|---|
Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи IART / Integra LifeSciences Holdings Corporation – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в IART / Integra LifeSciences Holdings Corporation. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
---|---|---|---|---|---|---|---|
Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных Peter J Arduini, раскрытый Комиссии по ценным бумагам и биржам (SEC).
Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -5 472 | 167 882 | -3,16 | 73,73 | -403 451 | 12 377 940 | |
2025-09-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -5 874 | 173 354 | -3,28 | 73,73 | -433 090 | 12 781 390 | |
2025-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 41 931 | 179 228 | 30,54 | ||||
2025-03-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -29 818 | 137 297 | -17,84 | 87,35 | -2 604 602 | 11 992 893 | |
2025-03-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -4 507 | 167 115 | -2,63 | 87,35 | -393 686 | 14 597 495 | |
2025-02-10 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 67 487 | 171 622 | 64,81 | ||||
2025-02-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -3 206 | 104 135 | -2,99 | 88,30 | -283 090 | 9 195 120 | |
2024-09-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -5 859 | 107 341 | -5,18 | 84,82 | -496 960 | 9 104 664 | |
2024-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 36 399 | 113 200 | 47,39 | ||||
2024-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | -4 444 | 76 801 | -5,47 | 91,28 | -405 648 | 7 010 395 | |
2023-03-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 39 425 | 81 245 | 94,27 | ||||
2023-02-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 21 425 | 41 820 | 105,05 | ||||
2022-04-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 462 | 38 266 | 1,22 | 73,03 | 33 750 | 2 794 574 | |
2022-03-03 |
|
4 | GE |
GENERAL ELECTRIC CO
Employee Stock Option (right to buy) |
A - Award | 63 044 | 63 044 | |||||
2022-03-03 |
|
4 | GE |
GENERAL ELECTRIC CO
Restricted Stock Units |
A - Award | 14 443 | 14 443 | |||||
2022-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 068 | 37 804 | 8,83 | 65,19 | 200 000 | 2 464 441 | |
2022-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 521 | 34 451 | 1,54 | 62,35 | 32 500 | 2 147 998 | |
2021-10-01 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 549 | 33 648 | 1,66 | ||||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -46 605 | 0 | -100,00 | |||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -46 605 | 216 713 | -17,70 | 75,75 | -3 530 459 | 16 416 617 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 46 605 | 263 318 | 21,51 | 20,88 | 973 112 | 5 498 080 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -71 829 | 46 605 | -60,65 | |||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -71 829 | 216 713 | -24,89 | 75,97 | -5 456 662 | 16 463 123 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 71 829 | 288 542 | 33,14 | 20,88 | 1 499 790 | 6 024 757 |
2021-07-01 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 507 | 32 862 | 1,57 | ||||
2021-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 574 | 32 112 | 1,82 | 63,13 | 36 250 | 2 027 207 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | -368 | 552 716 | -0,07 | 68,10 | -25 061 | 37 639 960 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | -272 | 553 084 | -0,05 | 68,10 | -18 523 | 37 665 020 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | -258 | 553 356 | -0,05 | 68,10 | -17 570 | 37 683 544 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -368 | 216 713 | -0,17 | 68,10 | -25 061 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 217 081 | 0,17 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -272 | 216 713 | -0,13 | 68,10 | -18 523 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 272 | 216 985 | 0,13 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -258 | 216 713 | -0,12 | 68,10 | -17 570 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 216 971 | 0,12 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 22 027 | 553 614 | 4,14 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 66 402 | 66 402 | |||||
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -22 786 | 0 | -100,00 | |||
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -22 786 | 216 713 | -9,51 | 66,16 | -1 507 442 | 14 336 974 |
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 22 786 | 239 499 | 10,51 | 15,79 | 359 791 | 3 781 689 |
2021-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 054 | 31 537 | 10,72 | 62,21 | 190 000 | 1 961 943 | |
2021-01-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 584 | 28 261 | 2,11 | 62,03 | 36 250 | 1 753 008 | |
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -45 000 | 22 786 | -66,39 | |||
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -45 000 | 216 713 | -17,19 | 61,97 | -2 788 780 | 13 430 333 |
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 45 000 | 261 713 | 20,76 | 15,79 | 710 550 | 4 132 448 |
2020-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 601 | 27 468 | 2,24 | 60,29 | 36 250 | 1 656 075 | |
2020-07-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 616 | 26 664 | 2,37 | 58,80 | 36 250 | 1 567 854 | |
2020-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 650 | 25 855 | 2,58 | 55,74 | 36 250 | 1 441 137 | |
2020-03-27 |
|
4/A | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 27 657 | 531 587 | 5,49 | ||||
2020-03-27 |
|
4/A | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 138 143 | 138 143 | |||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 41 485 | 545 415 | 8,23 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | -272 | 503 930 | -0,05 | 43,39 | -11 802 | 21 865 523 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | -258 | 504 202 | -0,05 | 43,39 | -11 195 | 21 877 325 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -290 | 504 460 | -0,06 | 43,39 | -12 583 | 21 888 519 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 92 096 | 92 096 | |||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -12 041 | 216 713 | -5,26 | 43,39 | -522 459 | 9 403 177 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -7 085 | 228 754 | -3,00 | 43,39 | -307 418 | 9 925 636 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -6 736 | 235 839 | -2,78 | 43,39 | -292 275 | 10 233 054 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -272 | 242 575 | -0,11 | 43,39 | -11 802 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 272 | 242 847 | 0,11 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -258 | 242 575 | -0,11 | 43,39 | -11 195 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 242 833 | 0,11 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -290 | 242 575 | -0,12 | 43,39 | -12 583 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 242 865 | 0,12 | ||||
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -32 316 | 0 | -100,00 | |||
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -32 316 | 242 575 | -11,76 | 55,68 | -1 799 332 | 13 506 406 |
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 32 316 | 274 891 | 13,32 | 13,89 | 448 869 | 3 818 236 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 540 | 32 316 | -9,87 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -21 960 | 35 856 | -37,98 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -3 540 | 242 575 | -1,44 | 57,12 | -202 190 | 13 854 889 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 3 540 | 246 115 | 1,46 | 13,89 | 49 171 | 3 418 537 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -21 960 | 242 575 | -8,30 | 57,12 | -1 254 265 | 13 854 889 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 21 960 | 264 535 | 9,05 | 13,89 | 305 024 | 3 674 391 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -37 704 | 57 816 | -39,47 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -37 704 | 242 575 | -13,45 | 58,21 | -2 194 923 | 14 121 407 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 37 704 | 280 279 | 15,54 | 13,89 | 523 709 | 3 893 075 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -20 344 | 95 520 | -17,56 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -20 344 | 242 575 | -7,74 | 59,56 | -1 211 729 | 14 448 252 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 20 344 | 262 919 | 8,39 | 13,89 | 282 578 | 3 651 945 |
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 16 316 | 242 575 | 7,21 | ||||
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 15 512 | 226 259 | 7,36 | ||||
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 27 730 | 210 747 | 15,15 | ||||
2020-02-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 018 | 25 204 | 13,60 | 62,95 | 190 000 | 1 586 610 | |
2020-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 565 | 22 030 | 2,63 | 64,19 | 36 250 | 1 414 112 | |
2019-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 715 | 21 312 | 3,47 | 50,71 | 36 250 | 1 080 757 | |
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -250 000 | 115 864 | -68,33 | |||
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -250 000 | 183 017 | -57,73 | 60,55 | -15 137 150 | 11 081 423 |
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 250 000 | 433 017 | 136,60 | 13,89 | 3 472 500 | 6 014 606 |
2019-07-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 768 | 20 412 | 3,91 | 45,35 | 34 808 | 925 707 | |
2019-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 681 | 19 474 | 3,62 | 47,71 | 32 500 | 929 083 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -368 | 504 750 | -0,07 | 56,14 | -20 660 | 28 336 665 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -15 292 | 183 017 | -7,71 | 56,14 | -858 493 | 10 274 574 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -368 | 198 309 | -0,19 | 56,14 | -20 660 | 11 133 067 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 198 677 | 0,19 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 20 390 | 505 118 | 4,21 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -258 | 484 728 | -0,05 | 55,91 | -14 425 | 27 101 142 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -290 | 484 986 | -0,06 | 55,91 | -16 214 | 27 115 567 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 91 249 | 91 249 | |||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -11 687 | 198 309 | -5,57 | 55,91 | -653 420 | 11 087 456 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -6 215 | 209 996 | -2,87 | 55,91 | -347 481 | 11 740 876 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -258 | 216 211 | -0,12 | 55,91 | -14 425 | 12 088 357 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 216 469 | 0,12 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -290 | 216 211 | -0,13 | 55,91 | -16 214 | 12 088 357 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 216 501 | 0,13 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 14 312 | 216 211 | 7,09 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 26 914 | 201 899 | 15,38 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 35 217 | 174 985 | 25,20 | ||||
2019-02-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 708 | 18 792 | 24,58 | 49,89 | 185 000 | 937 550 | |
2019-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 625 | 14 761 | 4,42 | 51,98 | 32 500 | 767 264 | |
2018-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 524 | 14 136 | 3,85 | 62,08 | 32 500 | 877 533 | |
2018-07-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 587 | 13 612 | 4,51 | 55,34 | 32 500 | 753 288 | |
2018-04-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 514 | 12 927 | 4,14 | 63,25 | 32 500 | 817 606 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -343 | 485 276 | -0,07 | 54,15 | -18 573 | 26 277 695 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -10 994 | 139 768 | -7,29 | 54,15 | -595 325 | 7 568 437 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -343 | 150 762 | -0,23 | 54,15 | -18 573 | 8 163 762 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 343 | 151 105 | 0,23 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -368 | 485 619 | -0,08 | 56,14 | -20 660 | 27 262 651 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -368 | 150 762 | -0,24 | 56,14 | -20 660 | 8 463 779 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 151 130 | 0,24 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -14 842 | 150 762 | -8,96 | 56,14 | -833 230 | 8 463 779 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -290 | 485 987 | -0,06 | 56,23 | -16 307 | 27 327 049 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 19 385 | 486 277 | 4,15 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 75 069 | 75 069 | |||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -290 | 165 604 | -0,17 | 56,23 | -16 307 | 9 311 913 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 165 894 | 0,18 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -11 687 | 165 604 | -6,59 | 56,23 | -657 160 | 9 311 913 | |
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 26 914 | 177 291 | 17,90 | ||||
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 34 182 | 150 377 | 29,42 | ||||
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 25 318 | 116 195 | 27,86 | ||||
2018-02-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 2 946 | 12 413 | 31,12 | 62,80 | 185 000 | 779 521 | |
2018-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 530 | 9 407 | 5,97 | 61,28 | 32 500 | 576 459 | |
2017-10-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 510 | 8 821 | 6,13 | 63,74 | 32 500 | 562 268 | |
2017-07-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 560 | 8 254 | 7,28 | 55,72 | 31 223 | 459 912 | |
2017-04-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 529 | 7 641 | 7,43 | 54,38 | 28 750 | 415 503 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -413 | 466 892 | -0,09 | 42,74 | -17 652 | 19 954 964 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -413 | 90 877 | -0,45 | 42,74 | -17 652 | 3 884 083 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 413 | 91 290 | 0,45 | ||||
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -13 640 | 90 877 | -13,05 | 42,74 | -582 974 | 3 884 083 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -353 | 467 305 | -0,08 | 42,35 | -14 950 | 19 790 367 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -353 | 104 517 | -0,34 | 42,35 | -14 950 | 4 426 295 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 353 | 104 870 | 0,34 | ||||
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -11 308 | 104 517 | -9,76 | 42,35 | -478 894 | 4 426 295 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -378 | 467 658 | -0,08 | 43,03 | -16 265 | 20 123 324 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -378 | 115 825 | -0,33 | 43,03 | -16 265 | 4 983 950 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 378 | 116 203 | 0,33 | ||||
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -15 730 | 115 825 | -11,96 | 43,03 | -676 862 | 4 983 950 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 21 750 | 468 036 | 4,87 | ||||
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 84 071 | 84 071 | |||||
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 000 | 311 588 | -11,38 | ||||
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -40 000 | 131 555 | -23,32 | 42,28 | -1 691 224 | 5 562 224 |
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 40 000 | 171 555 | 30,41 | 13,89 | 555 600 | 2 382 899 |
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -8 018 | 131 555 | -5,74 | 42,28 | -339 006 | 5 562 224 |
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 34 179 | 139 573 | 32,43 | ||||
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 24 570 | 105 394 | 30,40 | ||||
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 29 638 | 80 824 | 57,90 | ||||
2017-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 449 | 7 112 | 94,16 | 49,29 | 170 000 | 350 552 | |
2017-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 492 | 3 634 | 15,66 | 58,44 | 28 750 | 212 389 | |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | -20 000 | 175 794 | -10,21 | ||||
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -20 000 | 25 593 | -43,87 | 80,02 | -1 600 302 | 2 047 826 |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 20 000 | 45 593 | 78,15 | 27,78 | 555 600 | 1 266 574 |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -4 009 | 25 593 | -13,54 | 77,00 | -308 708 | 1 970 756 |
2016-10-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 533 | 3 119 | 20,62 | 53,92 | 28 750 | 168 178 | |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -12 009 | 195 794 | -5,78 | |||
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -12 009 | 29 602 | -28,86 | 84,65 | -1 016 557 | 2 505 797 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 12 009 | 41 611 | 40,57 | 27,78 | 333 610 | 1 155 954 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -7 991 | 207 803 | -3,70 | |||
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -7 991 | 29 602 | -21,26 | 84,19 | -672 757 | 2 492 175 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 7 991 | 37 593 | 26,99 | 27,78 | 221 990 | 1 044 334 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | -4 009 | 29 602 | -11,93 | 84,77 | -339 837 | 2 509 320 |
2016-07-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 373 | 2 573 | 16,95 | 73,55 | 27 431 | 189 243 | |
2016-04-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 2 188 | 2 188 | |||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -105 | 223 143 | -0,05 | 64,37 | -6 759 | 14 363 715 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
M - Exercise | -607 | 21 182 | -2,79 | 64,37 | -39 073 | 1 363 485 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -4 605 | 33 611 | -12,05 | 64,37 | -296 424 | 2 163 540 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -607 | 38 216 | -1,56 | 64,37 | -39 073 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 607 | 38 823 | 1,59 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -105 | 38 216 | -0,27 | 64,37 | -6 759 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 105 | 38 321 | 0,27 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -207 | 223 248 | -0,09 | 64,37 | -13 325 | 14 370 474 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -6 476 | 38 216 | -14,49 | 64,37 | -416 860 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -207 | 44 692 | -0,46 | 64,37 | -13 325 | 2 876 824 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 207 | 44 899 | 0,46 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -177 | 223 455 | -0,08 | 64,81 | -11 471 | 14 482 119 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -177 | 44 692 | -0,39 | 64,81 | -11 471 | 2 896 489 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 177 | 44 869 | 0,40 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -5 531 | 44 692 | -11,01 | 64,81 | -358 464 | 2 896 489 | |
2016-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 13 811 | 223 632 | 6,58 | ||||
2016-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 64 625 | 64 625 | |||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
A - Award | 14 800 | 21 789 | 211,76 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 12 285 | 50 223 | 32,38 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 14 384 | 37 938 | 61,07 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 6 783 | 23 554 | 40,44 | ||||
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -105 | 209 821 | -0,05 | 61,58 | -6 466 | 12 920 777 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
M - Exercise | -259 | 6 047 | -4,11 | 61,58 | -15 949 | 372 374 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -1 302 | 16 307 | -7,39 | 61,58 | -80 177 | 1 004 185 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -259 | 17 609 | -1,45 | 61,58 | -15 949 | 1 084 362 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | -259 | 17 868 | -1,43 | ||||
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -105 | 17 609 | -0,59 | 61,58 | -6 466 | 1 084 362 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 105 | 17 714 | 0,60 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -207 | 209 926 | -0,10 | 62,65 | -12 969 | 13 151 864 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -5 603 | 17 609 | -24,14 | 62,65 | -351 028 | 1 103 204 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -207 | 23 212 | -0,88 | 62,65 | -12 969 | 1 454 232 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 207 | 23 419 | 0,89 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 12 883 | 210 133 | 6,53 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 59 791 | 59 791 | |||||
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -248 | 197 250 | -0,13 | 56,99 | -14 134 | 11 241 278 | |
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -248 | 23 212 | -1,06 | 56,99 | -14 134 | 1 322 852 | |
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 248 | 23 460 | 1,07 | ||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
A - Award | 6 306 | 6 306 | |||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 12 444 | 23 212 | 115,56 | ||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 2 890 | 10 768 | 36,68 | ||||
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -1 390 | 197 498 | -0,70 | ||||
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -1 390 | 7 878 | -15,00 | 53,39 | -74 212 | 420 606 | |
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 390 | 9 268 | 17,64 | ||||
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
M - Exercise | -84 | 198 888 | -0,04 | 45,77 | -3 845 | 9 103 104 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -84 | 7 878 | -1,06 | 45,77 | -3 845 | 360 576 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 84 | 7 962 | 1,07 | ||||
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -880 | 7 878 | -10,05 | 45,77 | -40 278 | 360 576 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
A - Award | 15 083 | 198 972 | 8,20 | ||||
2014-03-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 56 727 | 56 727 | |||||
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -248 | 183 889 | -0,13 | 47,37 | -11 748 | 8 710 822 | |
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -248 | 8 758 | -2,75 | 47,37 | -11 748 | 414 866 | |
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 248 | 9 006 | 2,83 | ||||
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -1 401 | 184 137 | -0,76 | ||||
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -1 401 | 8 758 | -13,79 | 47,81 | -66 982 | 418 720 | |
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 401 | 10 159 | 16,00 | ||||
2013-05-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 32 468 | 32 468 | |||||
2013-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 7 644 | 185 538 | 4,30 | ||||
2013-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 8 758 | 8 758 | |||||
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -248 | 177 894 | -0,14 | 40,34 | -10 004 | 7 176 244 | |
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -149 | 178 142 | -0,08 | 40,34 | -6 011 | 7 186 248 | |
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -397 | 0 | -100,00 | 40,34 | -16 015 | ||
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 397 | 397 | |||||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | -1 423 | 178 291 | -0,79 | ||||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -1 423 | 0 | -100,00 | 39,54 | -56 265 | ||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 423 | 1 423 | |||||
2012-03-05 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 25 997 | 232 716 | 12,58 | ||||
2012-03-05 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 206 719 | 206 719 | |||||
2012-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (contract stock) |
A - Award | 4 537 | 179 714 | 2,59 | ||||
2012-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (contract stock) |
A - Award | 22 684 | 175 177 | 14,88 | ||||
2012-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 118 363 | 152 493 | 346,80 | ||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
M - Exercise | -738 | 34 130 | -2,12 | ||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
A - Award | 34 868 | 34 868 | |||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | -738 | 0 | -100,00 | 43,02 | -31 749 | ||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 738 | 738 | |||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 76 800 | 76 800 | |||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
A - Award | 8 700 | 49 767 | 21,18 | ||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
F - Taxes | -2 106 | 41 067 | -4,88 | 50,74 | -106 858 | 2 083 740 | |
2006-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 132 000 | 132 000 | |||||
2006-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
A - Award | 21 450 | 44 450 | 93,26 | ||||
2005-04-19 | 3 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
0 |